Advancing Pediatric Vaccinations and Well-child Visits

CLIENT

Health Resources Services Administration (HRSA), Maternal and Child Health Bureau (MCHB)

INDUSTRY

01

CASE

Promoting Pediatric Primary Prevention (P4) Challenge 

02

Overview

Well-child visits, which serve as an important venue for counseling, administration, and documentation of vaccines, have declined since the COVID-19 pandemic. To address this alarming trend, the Maternal and Child Health Bureau (MCHB) at the Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) selected Ensemble and Capital Consulting Corporation to design, launch, and manage a two-phase prize competition. The Promoting Pediatric Primary Prevention (P4) Challenge recently concluded its second phase and awarded $1,000,000 to health care organizations and community partners for designing and then implementing innovative approaches to increase access to and utilization of well-child visits and/or immunization services within primary care settings. The initial phase awarded $10,000 to 50 participating organizations that demonstrated a strong capability to increase well-child visits aimed at reversing the decline in visits and immunizations. The second phase, which concluded in January 2022, awarded 20 winning teams $25,000 each for their implementation of innovative approaches introduced in Phase 1.

03

OUR
Approach

Ensemble delivered this prize challenge program by :

1) Preparing and executing an outreach strategy, graphic design, and original content for reaching and engaging contestants to participate in this program

 2) Collecting, analyzing, organizing, and reporting submission data across the two phases. 

To ensure all target audiences were reached as part of the outreach campaign, Ensemble prepared a database capturing all relevant pediatric media outlets and engaged them with a pitch for them to cover this contest, with sample content for publications to easily draft blogs that highlight HRSA’s effort to increase well-child visits and immunizations. Additionally, Ensemble recruited over 20 advisor stakeholders to work alongside contestants for advancing their innovative approaches into actionable in their communities. These advisors include pediatrician practitioners, medical scholars and university professors, and pediatric nonprofit leaders representing diverse geographical and socioeconomic pockets of the US population. 

Upon the submission deadlines of both phases, Ensemble collected and reported on community well-child visit and immunization data participating teams submitted which included statistics such as number of well-child visits, well-child visit disparities, administered doses of specific vaccine, and coverage of the primary pediatric vaccination series disparities within the community on a specific immunization metric (comparing measure across two or more subpopulations). This data was analyzed and prepared to HRSA P4 Challenge stakeholders in the form of a Challenge Summary Report delivered within two weeks of the submission deadline of each phase.

05

Results

During the first round of the challenge, we received over 1,400 registrants.  50 teams around the U.S received $10,000 in prizes each to develop and implement their unique ideas to get more children to their annual well visits and receive vaccinations locally. Out of those 50 teams, 20 outstanding teams were awarded the Phase 2 prize of $25,000. The winners comprise local school districts, community organizations, pediatric clinics, and pediatric hospitals. Each of the winners impressed the judges of the challenge with their innovative and creative approaches to addressing disparities in well-child visits and childhood vaccinations in their communities. The solutions ranged from mobile vaccination units and Telehealth services to a local fair that coupled vaccinations with face painting and firetrucks. In many of the winning submissions, the number of children receiving vaccinations and getting their annual child well-visits doubled or tripled among target populations.